相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。LONG-TERM TREATMENT WITH PEGVISOMANT AS MONOTHERAPY IN PATIENTS WITH ACROMEGALY: EXPERIENCE FROM ACROSTUDY
Pamela U. Freda et al.
ENDOCRINE PRACTICE (2015)
Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Bone Turnover, Bone Mineral Density, and Fracture Risk in Acromegaly: A Meta-Analysis
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Preoperative somatostatin analogues versus direct transsphenoidal surgery for newly-diagnosed acromegaly patients: a systematic review and meta-analysis using the GRADE system
V. S. Nunes et al.
PITUITARY (2015)
Stereotactic radiosurgery for acromegaly: outcomes by adenoma subtype
Cheng-Chia Lee et al.
PITUITARY (2015)
ACROSTUDY: the Italian experience
S. Grottoli et al.
ENDOCRINE (2015)
An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly
Sauradeep Sarkar et al.
ACTA NEUROCHIRURGICA (2014)
Should all patients with acromegaly receive somatostatin analogue therapy before surgery and, if so, for how long?
Jubbin J. Jacob et al.
CLINICAL ENDOCRINOLOGY (2014)
AACE/ACE DISEASE STATE CLINICAL REVIEW: DOPAMINE AGONISTS FOR HYPERPROLACTINEMIA AND THE RISK OF CARDIAC VALVE DISEASE
Susan L. Samson et al.
ENDOCRINE PRACTICE (2014)
Preoperative octreotide treatment of acromegaly: long-term results of a randomised controlled trial
S. L. Fougner et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2014)
Relationship of PTTG Expression with Tumor Invasiveness and Microvessel Density of Pituitary Adenomas: A Meta-Analysis
Yan Li et al.
GENETIC TESTING AND MOLECULAR BIOMARKERS (2014)
Surgical Interventions and Medical Treatments in Treatment-Naive Patients With Acromegaly: Systematic Review and Meta-Analysis
Abd Moain Abu Dabrh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Tumor Shrinkage With Lanreotide Autogel 120 mg as Primary Therapy in Acromegaly: Results of a Prospective Multicenter Clinical Trial
Philippe J. Caron et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Stereotactic Radiosurgery for Acromegaly
Cheng-Chia Lee et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Acromegaly: An Endocrine Society Clinical Practice Guideline
Laurence Katznelson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
A. Colao et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Pharmacokinetics, Pharmacodynamics, and Safety of Pasireotide LAR in Patients With Acromegaly: A Randomized, Multicenter, Open-Label, Phase I Study
Stephan Petersenn et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Somatostatin receptor ligands and resistance to treatment in pituitary adenomas
Daniel Cuevas-Ramos et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2014)
Estrogen and selective estrogen receptor modulators (SERMs) for the treatment of acromegaly: a meta-analysis of published observational studies
Jennifer C. Stone et al.
PITUITARY (2014)
Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
Stephan Petersenn et al.
PITUITARY (2014)
Risk of Thyroid Nodular Disease and Thyroid Cancer in Patients with Acromegaly - Meta-Analysis and Systematic Review
Kosma Wolinski et al.
PLOS ONE (2014)
Factors Associated with Biochemical Remission after Microscopic Transsphenoidal Surgery for Acromegaly
Hai Sun et al.
JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2014)
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
Monica R. Gadelha et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Prevalence of diabetes mellitus in patients with acromegaly
A. V. Dreval et al.
ENDOCRINE CONNECTIONS (2014)
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment
Giuseppe Reimondo et al.
ENDOCRINE (2014)
Control of growth hormone and IGF1 in patients with acromegaly in the UK: responses to medical treatment with somatostatin analogues and dopamine agonists
Trevor A. Howlett et al.
CLINICAL ENDOCRINOLOGY (2013)
Functional evaluation of the joints in acromegalic patients and associated factors
Leandro Lemgruber Kropf et al.
CLINICAL RHEUMATOLOGY (2013)
Granulation pattern, but not GSP or GHR mutation, is associated with clinical characteristics in somatostatin-naive patients with somatotroph adenomas
Sarah Larkin et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Long-term outcome in patients with acromegaly: analysis of 1344 patients from the German Acromegaly Register
Christof Schoefl et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Ki-67 is a predictor of acromegaly control with octreotide LAR independent of SSTR2 status and relates to cytokeratin pattern
Leandro Kasuki et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Effects of medical therapies for acromegaly on glucose metabolism
C. Urbani et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Cardiovascular involvement in patients affected by acromegaly: An appraisal
Susanna Mosca et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
A Comprehensive Study of Clinical, Biochemical, Radiological, Vascular, Cardiac, and Sleep Parameters in an Unselected Cohort of Patients With Acromegaly Undergoing Presurgical Somatostatin Receptor Ligand Therapy
Anand K. Annamalai et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Endoscopic vs Microsurgical Transsphenoidal Surgery for Acromegaly: Outcomes in a Concurrent Series of Patients Using Modern Criteria For Remission
Robert M. Starke et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Acromegaly: A single centre's experience of stereotactic radiosurgery and radiotherapy for growth hormone secreting pituitary tumours with the linear accelerator
P. J. Wilson et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2013)
Predictors of endoscopic transsphenoidal surgery outcome in acromegaly: patient and tumor characteristics evaluated by magnetic resonance imaging
Christa C. van Bunderen et al.
PITUITARY (2013)
Pegvisomant and cabergoline combination therapy in acromegaly
I. Bernabeu et al.
PITUITARY (2013)
The role of primary pharmacological therapy in acromegaly
Ana Laura Espinosa de los Monteros et al.
Pituitary (2013)
Airway Management and Perioperative Concerns in Acromegaly Patients Undergoing Endoscopic Transsphenoidal Surgery for Pituitary Tumors
Mark E. Friedel et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2013)
Airway Management and Perioperative Concerns in Acromegaly Patients Undergoing Endoscopic Transsphenoidal Surgery for Pituitary Tumors
Mark E. Friedel et al.
OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2013)
Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery
Francoise Borson-Chazot et al.
ANNALES D ENDOCRINOLOGIE (2012)
Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression
Leandro Kasuki et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2012)
Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
Claudia Ramirez et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 Patients
Laure Cazabat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience
Francesco M. Minuto et al.
PITUITARY (2012)
Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis
Ferdinand Roelfsema et al.
PITUITARY (2012)
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly
Andrea Giustina et al.
PLOS ONE (2012)
Elevated incidence of sleep apnoea in acromegaly-correlation to disease activity
J. Roemmler et al.
SLEEP AND BREATHING (2012)
Resistance to Somatostatin Analogs in Acromegaly
Annamaria Colao et al.
ENDOCRINE REVIEWS (2011)
Place of Cabergoline in Acromegaly: A Meta-Analysis
Laure Sandret et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Endoscopic Transsphenoidal Surgery for Acromegaly: Remission Using Modern Criteria, Complications, and Predictors of Outcome
John A. Jane et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Endocrine outcomes in Endoscopic Pituitary Surgery: A Literature Review
Neil L. Dorward
ACTA NEUROCHIRURGICA (2010)
Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed
Tirissa J. Reid et al.
CLINICAL ENDOCRINOLOGY (2010)
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
Alberto Fernandez et al.
CLINICAL ENDOCRINOLOGY (2010)
Effect of presurgical long-acting octreotide treatment in acromegaly patients with invasive pituitary macroadenomas: a prospective randomized study
Ming Shen et al.
ENDOCRINE JOURNAL (2010)
Mortality in Patients with Pituitary Disease
Mark Sherlock et al.
ENDOCRINE REVIEWS (2010)
Preoperative lanreotide treatment in acromegalic patients with macroadenomas increases short-term postoperative cure rates: a prospective, randomised trial
Zhi-gang Mao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
Repeated colonoscopic screening of patients with acromegaly: 15-year experience identifies those at risk of new colonic neoplasia and allows for effective screening guidelines
D. Dworakowska et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)
The current status of IGF-I assays - A 2009 update
Jan Frystyk et al.
GROWTH HORMONE & IGF RESEARCH (2010)
Characterization of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Mutations in Familial Isolated Pituitary Adenoma Families
Susana Igreja et al.
HUMAN MUTATION (2010)
Pasireotide (SOM230) Demonstrates Efficacy and Safety in Patients with Acromegaly: A Randomized, Multicenter, Phase II Trial
S. Petersenn et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Magnetic Resonance Imaging as a Predictor of Response to Somatostatin Analogs in Acromegaly after Surgical Failure
Manel Puig-Domingo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A Consensus on Criteria for Cure of Acromegaly
A. Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Approach to the Patient with Persistent Acromegaly after Pituitary Surgery
Laurence Katznelson
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The role of stereotactic radiosurgery in the multimodal management of growth hormone-secreting pituitary adenomas
Christopher J. Stapleton et al.
NEUROSURGICAL FOCUS (2010)
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review
Gherardo Mazziotti et al.
PITUITARY (2010)
Role of the aryl hydrocarbon receptor-interacting protein in familial isolated pituitary adenoma
Joshua W. Cain et al.
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2010)
Long-term experience of pegvisomant therapy as a treatment for acromegaly
C. E. Higham et al.
CLINICAL ENDOCRINOLOGY (2009)
The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegaly
N. Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2009)
Radiation-induced hypopituitarism
Alberto Fernandez et al.
ENDOCRINE-RELATED CANCER (2009)
Combined treatment for acromegaly with long-acting somatostatin analogs and pegvisomant: long-term safety for up to 4.5 years (median 2.2 years) of follow-up in 86 patients
S. J. C. M. M. Neggers et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2009)
The MEN1 Gene and Pituitary Tumours
Sunita K. Agarwal et al.
HORMONE RESEARCH (2009)
Medical Therapy in Patients with Acromegaly: Predictors of Response and Comparison of Efficacy of Dopamine Agonists and Somatostatin Analogues
M. Sherlock et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Effects of Somatostatin Analogs on Glucose Homeostasis: A Metaanalysis of Acromegaly Studies
Gherardo Mazziotti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
The Utility of Oral Glucose Tolerance Testing for Diagnosis and Assessment of Treatment Outcomes in 166 Patients with Acromegaly
John D. Carmichael et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Guidelines for Acromegaly Management: An Update
S. Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Endoscopic pituitary surgery: a systematic review and meta-analysis Clinical article
Abtin Tabaee et al.
JOURNAL OF NEUROSURGERY (2009)
Cardiovascular Disturbances in Acromegaly
Daniela Fedrizzi et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2008)
Wide variation in surgical outcomes for acromegaly in the UK
P. R. Bates et al.
CLINICAL ENDOCRINOLOGY (2008)
Surgical debulking of pituitary macroadenomas causing acromegaly improves control by lanreotide
N. Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2008)
A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly
I. M. Holdaway et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Prevalence of sleep apnea and metabolic abnormalities in patients with acromegaly and analysis of cephalometric parameters by magnetic resonance imaging
Flavia R. B. van Haute et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Impact of musculoskeletal disease on quality of life in long-standing acromegaly
Anne Miller et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
A critical analysis of clinically available somatostatin analog formulations for therapy of acromegaly
Robert D. Murray et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: A prospective, randomized trial
Sven M. Carlsen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Growth hormone response during oral glucose tolerance test:: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index
Ayman M. Arafat et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Mortality in acromegaly: A meta analysis
O. M. Dekkers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Current diagnosis of acromegaly
Rocio A. Cordero et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2008)
Risk of colorectal neoplasm in patients with acromegaly: A meta-analysis
Theodoros Rokkas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2008)
Long-term efficacy and safety of combined treatment of somatostatin analogs and Pegvisomant in acromegaly
Sebastian J. C. M. M. Neggers et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Risk factors for development of coronary heart disease in patients with acromegaly: A five-year prospective study
Fausto Bogazzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Long-term (up to 18 years) effects on GH/IGF-1 hypersecretion and tumour size of primary somatostatin analogue (SSTa) therapy in patients with GH-secreting pituitary adenoma responsive to SSTa
Jean Christophe Maiza et al.
CLINICAL ENDOCRINOLOGY (2007)
Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia
Marianthi Georgitsi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Variation in GH and IGF-I assays limits the applicability of international consensus criteria to local practice
A. Pokrajac et al.
CLINICAL ENDOCRINOLOGY (2007)
Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly:: mutations are found in a subset of young patients with macroadenomas
Laure Cazabat et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR® (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly
Moises Mercado et al.
CLINICAL ENDOCRINOLOGY (2007)
Long-term follow-up of patients with pituitary macroadenomas after postoperative radiation therapy - Analysis of tumor control and functional outcome
Tanja Langsenlehner et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2007)
Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas:: Analysis in 73 families
Adrian F. Daly et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis
Sosipatros A. Boikos et al.
HUMAN MOLECULAR GENETICS (2007)
Treatment of acromegaly: is there still a place for radiotherapy?
Raquel S. Jallad et al.
PITUITARY (2007)
Carney complex: the first 20 years
Sosipatros A. Boikos et al.
CURRENT OPINION IN ONCOLOGY (2007)
Treatment of acromegaly with the GH receptor antagonist pegvisomant in clinical practice: Safety and efficacy evaluation from the German Pegvisomant Observational Study
I. Schreiber et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2007)
Germ-line mutations in p27Kip1 cause a multiple endocrine neoplasia syndrome in rats and humans
Natalia S. Pellegata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years
K. Abbassioun et al.
SURGICAL NEUROLOGY (2006)
Presurgical treatment with somatostatin analogs in patients with acromegaly:: effects on the remission and complication rates
M Losa et al.
JOURNAL OF NEUROSURGERY (2006)
Gamma knife radiosurgery for acromegaly -: long-term experience
J Jezková et al.
CLINICAL ENDOCRINOLOGY (2006)
Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly
PJ Jenkins et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Primary treatment of acromegaly with octreotide LAR: a long-term (up to nine years) prospective study of its efficacy in the control of disease activity and tumor shrinkage
R Cozzi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on lGF-I levels, tumor mass, hypertension and glucose tolerance
A Colao et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2006)
Quality of life in acromegaly
Susan M. Webb
NEUROENDOCRINOLOGY (2006)
Transsphenoidal microsurgery for newly diagnosed acromegaly: A personal view after more than 1,000 operations
Dieter K. Luedecke et al.
NEUROENDOCRINOLOGY (2006)
Postoperative evaluation of patients with acromegaly: Clinical significance and timing of oral glucose tolerance testing and measurement of (free) insulin-like growth factor I, acid-labile subunit, and growth hormone-binding protein levels
RA Feelders et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The implication of somatotroph adenoma phenotype to somatostatin analog responsiveness in acromegaly
S Bhayana et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant
AL Barkan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Long-acting somatostatin analog therapy of acromegaly: A meta- analysis
PU Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
CLINICAL REVIEW: A critical analysis of pituitary tumor shrinkage during primary medical therapy in acromegaly
S Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life
NR Biermasz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Clinical review: Diagnosis and management of pituitary carcinomas
GA Kaltsas et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly
JJ Puder et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical 'cure'
P Nomikos et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2005)
The value of an acute octreotide suppression test in predicting long-term responses to depot somatostatin analogues in patients with active acromegaly
N Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2005)
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas
G Minniti et al.
CLINICAL ENDOCRINOLOGY (2005)
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: Update after an additional 10 years
G Minniti et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Colonoscopic screening and follow-up in patients with acromegaly: A multicenter study in Italy
M Terzolo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Clinical review 166 - Growth hormone receptor antagonists
AF Muller et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly
J Ayuk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly
O Serri et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Significance of abnormal nadir growth hormone levels after oral glucose in postoperative patients with acromegaly in remission with normal insulin-like growth factor-I levels
PU Freda et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Systemic complications of acromegaly: Epidemiology, pathogenesis, and management
A Colao et al.
ENDOCRINE REVIEWS (2004)
Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status
R Cozzi et al.
CLINICAL ENDOCRINOLOGY (2004)
Increased prevalence of regurgitant valvular heart disease in acromegaly
AM Pereira et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Determinants of survival in treated acromegaly in a single center: Predictive value of serial insulin-like growth factor I measurements
NR Biermasz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®
P Caron et al.
CLINICAL ENDOCRINOLOGY (2004)
Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espahol de Acromegalia, REA)
A Mestrón et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2004)
Long-term treatment outcome in acromegaly
IM Holdaway et al.
GROWTH HORMONE & IGF RESEARCH (2003)
Comparison of growth hormone-producing and non-growth hormone-producing pituitary adenomas: Imaging characteristics and pathologic correlation
A Hagiwara et al.
RADIOLOGY (2003)
Current concepts in the biochemical assessment of the patient with acromegaly
PU Freda
GROWTH HORMONE & IGF RESEARCH (2003)
Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study
R Attanasio et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Assessment of long-term remission of acromegaly following surgery
MD Krieger et al.
JOURNAL OF NEUROSURGERY (2003)
Radiotherapy and stereotactic radiosurgery for pituitary tumors
Z Petrovich et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2003)
Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly
C Beauregard et al.
CLINICAL ENDOCRINOLOGY (2003)
Improvement of left ventricular hypertrophy and arrhythmias after lanreoticle-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study
G Lombardi et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2002)
Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization
BE Pollock et al.
JOURNAL OF NEUROSURGERY (2002)
Acromegaly with apparently normal GH secretion: Implications for diagnosis and follow-up
EV Dimaraki et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: Should we achieve strict normal GH levels for a biochemical cure?
ACF Costa et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: secreting versus non-secreting adenomas
ML Jaffrain-Rea et al.
ENDOCRINE-RELATED CANCER (2002)
SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile
C Bruns et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
AJ van der Lely et al.
LANCET (2001)
Endocrine manifestations of stimulatory G protein α-subunit mutations and the role of genomic imprinting
LS Weinstein et al.
ENDOCRINE REVIEWS (2001)
Surgical management of GH-secreting pituitary adenomas: An outcome study using modern remission criteria
J Kreutzer et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Fractionated stereotactically guided radiotherapy and radiosurgery in the treatment of functional and nonfunctional adenomas of the pituitary gland
S Milker-Zabel et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Bone metabolism and body composition in Japanese patients with active acromegaly
H Kaji et al.
CLINICAL ENDOCRINOLOGY (2001)
Somatostatin receptor subtype expression in human tumors
LJ Hofland et al.
ANNALS OF ONCOLOGY (2001)
The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: Impact of surgery or radiotherapy
SR Peacey et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Growth hormone receptor antagonist therapy in acromegalic patients resistant to somatostatin analogs
VS Herman-Bonert et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Long-term follow-up results of postoperative radiotherapy in 36 patients with acromegaly
NR Biermasz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant
PJ Trainer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Impaired β-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients
S Kasayama et al.
CLINICAL ENDOCRINOLOGY (2000)
Criteria for cure of acromegaly: A consensus statement
A Giustina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2000)
Prevalence of diabetes in acromegaly and Cushing's disease
H Biering et al.
ACTA MEDICA AUSTRIACA (2000)
分享论文
